Skip to main content
. Author manuscript; available in PMC: 2011 Jun 21.
Published in final edited form as: Obstet Gynecol. 2010 Apr;115(4):745–752. doi: 10.1097/AOG.0b013e3181d4450d

Table 1.

Baseline Characteristics of Participants by STI Testing Method Selected.

Home (n = 305) Clinic (n = 98) p value
Mean age (SD) 25.1 (5.4) 24.7 (5.2) 0.48
Race/Ethnicity
 Black 83 (27.5) 41 (42.3)
 White 196 (64.9) 50 (51.5)
 Other 23 (7.6) 6 (6.2) 0.02
Education
 Less than high school diploma 35 (11.5) 8 (8.2)
 High school diploma or GED 56 (18.4) 21 (21.4)
 Some college 118 (38.6) 43 (43.9)
 College or graduate degree 96 (31.5) 26 (26.5) 0.53
Monthly individual income
 $0–800 92 (30.2) 33 (33.7)
 $801–1,600 75 (24.6) 27 (27.6)
 $1,601+ 73 (23.9) 21 (21.4)
 Refused or missing 65 (21.3) 17 (17.3) 0.72
Marital Status
 Never Married 204 (66.9) 69 (70.4)
 Married/Living with a Partner 85 (27.9) 23 (23.5)
 Separated/Divorced/Widowed 16 (5.2) 6 (6.1) 0.68
Contraceptive Method
 LARC (IUC or Implanon) 199 (65.3) 65 (66.3)
 DMPA 8 (2.6) 4 (4.1)
 Short-term refillable contraceptive (OC, patch, vaginal ring) 97 (31.8) 29 (29.6)
 Barrier (Diaphragm, condom) 1 (0.3) 0 (0) 0.75
Obtained health care in the last 12 months 271 (88.9) 88 (89.8) 0.79
No health insurance 104 (35.4) 38 (39.6) 0.46
History of STI* 78 (25.7) 28 (28.6) 0.58
STI** diagnosed at enrollment 4 (1.5) 4 (4.7) 0.11
Mean number of lifetime male sexual partners (SD) 8.6 (8.6) 10.5 (9.2) 0.07

SD, standard deviation; GED, general education development test; LARC, long-acting reversible contraceptive; IUC, intrauterine contraceptive; DMPA, depomedroxyprogesterone; OC, oral contraceptive; STI, sexually transmitted infection. Data are n (%) unless otherwise indicated.

*

STI includes chlamydia, gonorrhea, trichomoniasis, syphilis, HIV, and genital herpes.

**

Includes chlamydia, gonorrhea, trichomoniasis, syphilis, and HIV, for which each participant is screened at baseline.

Fisher’s exact test.